Telemedicine for Insulin Treated Gestational Diabetes Mellitus (TeleGDM)

Not Applicable

Recruiting

• Conditions: Metabolic and Endocrine - Diabetes; Gestational Diabetes Mellitus

• Registration Number: ACTRN12614000934640
• Lead Sponsor: The University of Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-09-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

IADPSG criteria based clinical diagnosis of GDM confirmed by OGTT

24-33 weeks of gestation or earlier diagnosis if in high risk group

Management of hyperglycaemia with insulin and no more than 35 weeks gestation.

Smartphone/tablet with internet access and/or internet connected personal computer

Not requiring an interpreter to navigate through the health care system

Exclusion Criteria

Adequate blood glucose control without insulin

Other pre-existing (pre-pregnancy) diabetes mellitus (T1DM or T2DM) or glucose intolerance.

Currently taking or took corticosteroids in the previous 3months.

Require an interpreter to navigate the healthcare system.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient service utilisation: Assessed as a composite of scheduled face-to-face consultations, unscheduled face-to-face consultations, and telephone consultations<br><br>GDM consultation encounters data will be collated from hospital medical records.[From enrollment to baby delivery. <br><br>]